Rapport Therapeutics, Inc. (RAPP) Q4 2024 Annual Earnings
RAPP·Reported March 11, 2025·Before market open
Diluted EPS came in at $-0.57, beat the $-0.62 consensus by $0.05.
Diluted EPS
$-0.57beat by $0.05
Consensus: $-0.62
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Rapport Therapeutics, Inc.'s Q4 2024 earnings report.
Rapport Therapeutics, Inc. (RAPP) reported Q4 2024 earnings on March 11, 2025 before market open.
Rapport Therapeutics, Inc. reported diluted EPS of $-0.57 for Q4 2024.
EPS beat the consensus estimate of $-0.62 by $0.05.
You can read the 10-K periodic report (0000950170-25-036828) directly on SEC EDGAR. The filing index links above go to sec.gov.